Symbols / EUDA Stock $14.38 +1.55% EUDA Health Holdings Limited
EUDA (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.
Ratings
Current target
$14.38
Low
$55.00
High
$55.00
Mean
$55.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-09 | main | Greenridge Global | Buy → Buy | $3 |
- EUDA Health Holdings Limited Receives Nasdaq MVLS Notice with 180-Day Compliance Period to Regain Listing Status - Quiver Quantitative Mon, 27 Apr 2026 07
- EUDA has until Oct. 20 to fix Nasdaq $35M listing shortfall - Stock Titan Mon, 27 Apr 2026 07
- EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities - Scott Coop Mon, 27 Apr 2026 10
- 12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga hu, 23 Apr 2026 07
- EUDA Health executes 1-for-20 reverse stock split - Investing.com hu, 19 Mar 2026 07
- EUDA Health price target lowered to $2.75 from $6 at Greenridge - Yahoo Finance ue, 10 Mar 2026 07
- Euda Health Holdings stock (US29821P1030): Trading at 14.40 USD with 4.65% gain - AD HOC NEWS ue, 12 May 2026 19
- Thursday's after hours session: top gainers and losers - ChartMill hu, 23 Apr 2026 07
- TradingKey - TradingKey ue, 12 May 2026 09
- EUDA Health Showcases Shenzhen Inno’s Government-Backed TCR-T Cell Therapy Program - TipRanks ue, 28 Apr 2026 07
- EUDA Health Soars: Is a Boom Coming? - StocksToTrade Wed, 24 Dec 2025 08
- A China-approved T-cell therapy project linked to EUDA targets solid tumors - Stock Titan ue, 28 Apr 2026 07
- EUDA Health Holdings Limited Completes Repurchase and Cancellation of Warrant from Streeterville Capital, LLC - Quiver Quantitative Wed, 04 Mar 2026 08
- EUDA Health receives Nasdaq delisting warning over market value - Investing.com Mon, 27 Apr 2026 07
- EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development - Scott Coop ue, 28 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
6.82
+70.04%
|
4.01
+8.22%
|
3.71
-1.54%
|
3.76
|
| Operating Revenue |
|
6.82
+70.04%
|
4.01
+8.22%
|
3.71
-1.54%
|
3.76
|
| Cost Of Revenue |
|
3.83
+17.81%
|
3.25
+13.42%
|
2.86
-1.03%
|
2.89
|
| Reconciled Cost Of Revenue |
|
3.83
+17.81%
|
3.25
+13.42%
|
2.86
-1.03%
|
2.89
|
| Gross Profit |
|
2.99
+292.68%
|
0.76
-9.49%
|
0.84
-3.21%
|
0.87
|
| Operating Expense |
|
5.43
+62.59%
|
3.34
-30.43%
|
4.80
-28.85%
|
6.75
|
| Research And Development |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.02
|
| Selling General And Administration |
|
5.43
+62.58%
|
3.34
-30.43%
|
4.80
-28.85%
|
6.75
|
| Selling And Marketing Expense |
|
1.28
+888.54%
|
0.13
-75.66%
|
0.53
-42.97%
|
0.94
|
| General And Administrative Expense |
|
4.15
+29.19%
|
3.21
-24.77%
|
4.27
-26.58%
|
5.82
|
| Other Gand A |
|
4.15
+29.19%
|
3.21
-24.77%
|
4.27
-26.58%
|
5.82
|
| Total Expenses |
|
9.26
+40.52%
|
6.59
-14.05%
|
7.67
-20.50%
|
9.64
|
| Operating Income |
|
-2.44
+5.39%
|
-2.58
+34.88%
|
-3.96
+32.64%
|
-5.88
|
| Total Operating Income As Reported |
|
-2.48
+85.71%
|
-17.34
-337.64%
|
-3.96
+67.58%
|
-12.22
|
| EBITDA |
|
-2.09
+88.00%
|
-17.42
-110.13%
|
-8.29
+66.51%
|
-24.76
|
| Normalized EBITDA |
|
-2.03
+8.66%
|
-2.22
+40.10%
|
-3.71
+32.75%
|
-5.51
|
| Reconciled Depreciation |
|
0.41
+134.66%
|
0.17
+45.14%
|
0.12
-30.62%
|
0.17
|
| EBIT |
|
-2.50
+85.81%
|
-17.60
-109.20%
|
-8.41
+66.27%
|
-24.93
|
| Total Unusual Items |
|
-0.06
+99.59%
|
-15.20
-231.59%
|
-4.59
+76.18%
|
-19.25
|
| Total Unusual Items Excluding Goodwill |
|
-0.06
+99.59%
|
-15.20
-231.59%
|
-4.59
+76.18%
|
-19.25
|
| Special Income Charges |
|
-0.04
+99.75%
|
-15.20
-2254.91%
|
-0.65
+89.81%
|
-6.34
|
| Other Special Charges |
|
—
|
0.45
-30.61%
|
0.65
|
—
|
| Impairment Of Capital Assets |
|
0.04
-99.75%
|
14.76
|
0.00
-100.00%
|
1.14
|
| Restructuring And Mergern Acquisition |
|
—
|
0.00
|
0.00
-100.00%
|
5.20
|
| Net Income |
|
-2.77
+81.94%
|
-15.36
-52.97%
|
-10.04
+59.66%
|
-24.88
|
| Pretax Income |
|
-2.73
+84.55%
|
-17.64
-109.16%
|
-8.43
+66.30%
|
-25.03
|
| Net Non Operating Interest Income Expense |
|
-0.23
-409.30%
|
-0.04
-93.28%
|
-0.02
+75.24%
|
-0.09
|
| Interest Expense Non Operating |
|
0.23
+409.30%
|
0.04
+93.28%
|
0.02
-75.24%
|
0.09
|
| Net Interest Income |
|
-0.23
-409.30%
|
-0.04
-93.28%
|
-0.02
+75.24%
|
-0.09
|
| Interest Expense |
|
0.23
+409.30%
|
0.04
+93.28%
|
0.02
-75.24%
|
0.09
|
| Other Income Expense |
|
-0.06
+99.62%
|
-15.02
-237.44%
|
-4.45
+76.64%
|
-19.05
|
| Other Non Operating Income Expenses |
|
0.01
-96.86%
|
0.19
+38.10%
|
0.13
-31.28%
|
0.20
|
| Gain On Sale Of Security |
|
-0.03
|
—
|
-3.94
+69.49%
|
-12.91
|
| Gain On Sale Of Business |
|
—
|
—
|
—
|
0.03
|
| Tax Provision |
|
0.04
+1057.64%
|
-0.00
|
0.00
+100.00%
|
-0.02
|
| Tax Rate For Calcs |
|
0.00
+68448.39%
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.01
-181.46%
|
-0.00
|
0.00
+100.00%
|
-0.02
|
| Net Income Including Noncontrolling Interests |
|
-2.77
+82.02%
|
-15.39
-53.36%
|
-10.04
+59.77%
|
-24.95
|
| Net Income From Continuing Operation Net Minority Interest |
|
-2.77
+84.25%
|
-17.60
-108.62%
|
-8.44
+66.17%
|
-24.94
|
| Net Income From Continuing And Discontinued Operation |
|
-2.77
+81.94%
|
-15.36
-52.97%
|
-10.04
+59.66%
|
-24.88
|
| Net Income Continuous Operations |
|
-2.77
+84.31%
|
-17.64
-109.11%
|
-8.43
+66.27%
|
-25.01
|
| Net Income Discontinuous Operations |
|
0.00
-100.00%
|
2.25
+240.28%
|
-1.60
-2829.88%
|
0.06
|
| Minority Interests |
|
-0.01
-114.73%
|
0.03
+1115.31%
|
-0.00
-105.19%
|
0.07
|
| Normalized Income |
|
-2.72
-13.20%
|
-2.40
+37.62%
|
-3.85
+32.54%
|
-5.71
|
| Net Income Common Stockholders |
|
-2.77
+81.94%
|
-15.36
-52.97%
|
-10.04
+59.66%
|
-24.88
|
| Diluted EPS |
|
—
|
-9.46
-7.87%
|
-8.77
+78.82%
|
-41.40
|
| Basic EPS |
|
—
|
-9.46
-7.87%
|
-8.77
+78.82%
|
-41.40
|
| Basic Average Shares |
|
—
|
1.62
+41.74%
|
1.15
+90.37%
|
0.60
|
| Diluted Average Shares |
|
—
|
1.62
+41.74%
|
1.15
+90.37%
|
0.60
|
| Diluted NI Availto Com Stockholders |
|
-2.77
+81.94%
|
-15.36
-52.97%
|
-10.04
+59.66%
|
-24.88
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1.72
+1.10%
|
1.70
+29.55%
|
1.31
-94.89%
|
25.63
|
| Current Assets |
|
1.04
+36.24%
|
0.76
+5.45%
|
0.72
-97.11%
|
25.03
|
| Cash Cash Equivalents And Short Term Investments |
|
0.35
+45.26%
|
0.24
+25.71%
|
0.19
+228.47%
|
0.06
|
| Cash And Cash Equivalents |
|
0.35
+45.26%
|
0.24
+25.71%
|
0.19
+228.47%
|
0.06
|
| Cash Financial |
|
0.35
+45.26%
|
0.24
+25.71%
|
0.19
+228.47%
|
0.06
|
| Receivables |
|
0.33
+96.28%
|
0.17
-28.81%
|
0.24
-98.92%
|
22.09
|
| Accounts Receivable |
|
0.24
+65.98%
|
0.15
-38.45%
|
0.24
+23.14%
|
0.19
|
| Gross Accounts Receivable |
|
0.25
+65.00%
|
0.15
-38.08%
|
0.24
+24.44%
|
0.19
|
| Allowance For Doubtful Accounts Receivable |
|
-0.00
-6.24%
|
-0.00
+3.35%
|
-0.00
|
0.00
|
| Other Receivables |
|
0.08
+1705.13%
|
0.00
+168.61%
|
0.00
-99.99%
|
21.90
|
| Inventory |
|
0.00
-97.79%
|
0.13
|
0.00
|
—
|
| Finished Goods |
|
0.00
-97.79%
|
0.13
|
0.00
|
—
|
| Prepaid Assets |
|
—
|
—
|
—
|
0.01
|
| Restricted Cash |
|
—
|
—
|
0.00
-100.00%
|
0.64
|
| Assets Held For Sale Current |
|
—
|
0.00
-100.00%
|
0.10
-95.07%
|
2.08
|
| Other Current Assets |
|
0.36
+58.02%
|
0.23
+17.47%
|
0.19
+23.84%
|
0.16
|
| Total Non Current Assets |
|
0.68
-27.57%
|
0.93
+59.26%
|
0.59
-2.57%
|
0.60
|
| Net PPE |
|
0.33
+5.07%
|
0.32
+52.79%
|
0.21
+221.69%
|
0.06
|
| Gross PPE |
|
0.44
+8.78%
|
0.41
+46.02%
|
0.28
+114.15%
|
0.13
|
| Accumulated Depreciation |
|
-0.11
-21.72%
|
-0.09
-26.52%
|
-0.07
-9.05%
|
-0.07
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.24
+40.80%
|
0.17
+119.25%
|
0.08
+1.51%
|
0.08
|
| Other Properties |
|
0.19
-14.68%
|
0.23
+14.13%
|
0.20
+279.15%
|
0.05
|
| Leases |
|
0.01
+9.43%
|
0.01
+402.18%
|
0.00
+1.49%
|
0.00
|
| Goodwill And Other Intangible Assets |
|
0.16
-52.14%
|
0.34
|
0.00
|
0.00
|
| Goodwill |
|
—
|
—
|
—
|
0.00
|
| Other Intangible Assets |
|
0.16
-52.14%
|
0.34
|
—
|
—
|
| Non Current Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Non Current Prepaid Assets |
|
0.18
-34.80%
|
0.28
-25.97%
|
0.38
-20.50%
|
0.48
|
| Other Non Current Assets |
|
—
|
—
|
—
|
0.06
|
| Total Liabilities Net Minority Interest |
|
5.98
+40.15%
|
4.27
-51.44%
|
8.79
-69.82%
|
29.14
|
| Current Liabilities |
|
5.84
+40.91%
|
4.14
-52.49%
|
8.72
-70.07%
|
29.12
|
| Payables And Accrued Expenses |
|
2.85
+16.87%
|
2.44
-12.58%
|
2.79
+5.10%
|
2.66
|
| Payables |
|
0.89
+5.38%
|
0.84
-7.11%
|
0.91
-37.80%
|
1.46
|
| Accounts Payable |
|
0.01
-45.35%
|
0.03
+1908.22%
|
0.00
|
0.00
|
| Other Payable |
|
—
|
—
|
0.00
-12.20%
|
0.00
|
| Current Accrued Expenses |
|
1.96
+22.95%
|
1.60
-15.21%
|
1.88
+57.48%
|
1.20
|
| Total Tax Payable |
|
0.09
-67.49%
|
0.26
+26.07%
|
0.21
+77.52%
|
0.12
|
| Income Tax Payable |
|
0.01
+264.94%
|
0.00
-82.16%
|
0.02
-73.74%
|
0.06
|
| Current Debt And Capital Lease Obligation |
|
2.33
+91.15%
|
1.22
-62.99%
|
3.30
-8.75%
|
3.62
|
| Current Debt |
|
2.20
+111.27%
|
1.04
-67.17%
|
3.17
-11.19%
|
3.57
|
| Other Current Borrowings |
|
2.20
+111.27%
|
1.04
-67.17%
|
3.17
-6.75%
|
3.40
|
| Current Capital Lease Obligation |
|
0.13
-25.73%
|
0.18
+41.41%
|
0.13
+190.53%
|
0.04
|
| Current Deferred Liabilities |
|
0.52
+9.23%
|
0.48
|
0.00
|
—
|
| Current Deferred Revenue |
|
0.52
+9.23%
|
0.48
|
0.00
|
—
|
| Other Current Liabilities |
|
0.12
|
—
|
2.62
-88.51%
|
22.85
|
| Total Non Current Liabilities Net Minority Interest |
|
0.15
+15.60%
|
0.13
+71.09%
|
0.08
+400.24%
|
0.02
|
| Long Term Debt And Capital Lease Obligation |
|
0.07
+30.24%
|
0.05
-31.03%
|
0.08
+400.24%
|
0.02
|
| Long Term Capital Lease Obligation |
|
0.07
+30.24%
|
0.05
-31.03%
|
0.08
+400.24%
|
0.02
|
| Non Current Deferred Liabilities |
|
0.08
+5.71%
|
0.08
|
0.00
|
0.00
|
| Non Current Deferred Taxes Liabilities |
|
0.08
+5.71%
|
0.08
|
0.00
|
0.00
|
| Stockholders Equity |
|
-4.25
-66.66%
|
-2.55
+65.95%
|
-7.50
-113.00%
|
-3.52
|
| Common Stock Equity |
|
-4.25
-66.66%
|
-2.55
+65.95%
|
-7.50
-113.00%
|
-3.52
|
| Capital Stock |
|
48.83
+2.14%
|
47.81
+74.29%
|
27.43
+28.73%
|
21.31
|
| Common Stock |
|
48.83
+2.14%
|
47.81
+74.29%
|
27.43
+28.73%
|
21.31
|
| Share Issued |
|
1.89
+1.76%
|
1.86
+50.86%
|
1.23
+10.09%
|
1.12
|
| Ordinary Shares Number |
|
1.89
+1.76%
|
1.86
+50.86%
|
1.23
+10.09%
|
1.12
|
| Retained Earnings |
|
-52.87
-5.53%
|
-50.10
-44.20%
|
-34.74
-40.64%
|
-24.70
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.21
+18.71%
|
-0.26
-39.93%
|
-0.19
-47.56%
|
-0.13
|
| Minority Interest |
|
-0.01
+33.84%
|
-0.02
-214.41%
|
0.02
+23.27%
|
0.01
|
| Other Equity Adjustments |
|
-0.21
+18.71%
|
-0.26
-39.93%
|
-0.19
-47.56%
|
-0.13
|
| Total Equity Gross Minority Interest |
|
-4.27
-65.92%
|
-2.57
+65.62%
|
-7.48
-113.34%
|
-3.51
|
| Total Capitalization |
|
-4.25
-66.66%
|
-2.55
+65.95%
|
-7.50
-113.00%
|
-3.52
|
| Working Capital |
|
-4.80
-41.96%
|
-3.38
+57.74%
|
-7.99
-95.23%
|
-4.09
|
| Invested Capital |
|
-2.05
-35.92%
|
-1.51
+65.06%
|
-4.33
-8464.89%
|
0.05
|
| Total Debt |
|
2.40
+88.67%
|
1.27
-62.28%
|
3.37
-7.06%
|
3.63
|
| Net Debt |
|
1.86
+130.78%
|
0.80
-73.05%
|
2.98
-15.11%
|
3.51
|
| Capital Lease Obligations |
|
0.20
-13.18%
|
0.23
+14.47%
|
0.20
+244.20%
|
0.06
|
| Net Tangible Assets |
|
-4.42
-52.80%
|
-2.89
+61.45%
|
-7.50
-113.00%
|
-3.52
|
| Tangible Book Value |
|
-4.42
-52.80%
|
-2.89
+61.45%
|
-7.50
-113.00%
|
-3.52
|
| Current Notes Payable |
|
—
|
—
|
0.00
-100.00%
|
0.17
|
| Duefrom Related Parties Current |
|
0.01
-55.76%
|
0.02
|
0.00
-100.00%
|
0.27
|
| Dueto Related Parties Current |
|
0.79
+42.26%
|
0.56
-20.26%
|
0.70
-48.06%
|
1.34
|
| Interest Payable |
|
0.00
-100.00%
|
0.00
-98.24%
|
0.25
+59.12%
|
0.16
|
| Line Of Credit |
|
—
|
—
|
—
|
0.19
|
| Non Current Note Receivables |
|
—
|
—
|
—
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-2.43
-19.26%
|
-2.03
+30.27%
|
-2.92
-91.11%
|
-1.53
|
| Cash Flow From Continuing Operating Activities |
|
-2.43
-19.80%
|
-2.03
+36.97%
|
-3.21
-3560.44%
|
-0.09
|
| Cash From Discontinued Operating Activities |
|
0.00
+100.00%
|
-0.01
-103.09%
|
0.30
+120.57%
|
-1.44
|
| Net Income From Continuing Operations |
|
-2.77
+84.31%
|
-17.64
-109.11%
|
-8.43
+66.27%
|
-25.01
|
| Depreciation Amortization Depletion |
|
0.41
+134.66%
|
0.17
+45.14%
|
0.12
-30.62%
|
0.17
|
| Depreciation |
|
0.25
+63.23%
|
0.15
+28.23%
|
0.12
+112.71%
|
0.06
|
| Amortization Cash Flow |
|
0.16
+676.62%
|
0.02
|
0.00
-100.00%
|
0.12
|
| Depreciation And Amortization |
|
0.41
+134.66%
|
0.17
+45.14%
|
0.12
-30.62%
|
0.17
|
| Amortization Of Intangibles |
|
0.16
+676.62%
|
0.02
|
0.00
-100.00%
|
0.12
|
| Other Non Cash Items |
|
—
|
—
|
1.30
-92.84%
|
18.11
|
| Provisionand Write Offof Assets |
|
0.00
-100.00%
|
0.04
+1722.37%
|
0.00
-99.91%
|
2.76
|
| Asset Impairment Charge |
|
0.12
-99.16%
|
14.76
|
0.00
-100.00%
|
1.14
|
| Deferred Tax |
|
0.00
+200.00%
|
-0.00
|
0.00
+100.00%
|
-0.05
|
| Deferred Income Tax |
|
0.00
+200.00%
|
-0.00
|
0.00
+100.00%
|
-0.05
|
| Operating Gains Losses |
|
0.04
-91.92%
|
0.45
-86.31%
|
3.27
+10984.80%
|
-0.03
|
| Gain Loss On Investment Securities |
|
0.03
|
—
|
2.64
|
—
|
| Gain Loss On Sale Of PPE |
|
0.01
|
0.00
|
0.00
|
—
|
| Change In Working Capital |
|
-0.23
-218.01%
|
0.19
-63.30%
|
0.53
-80.94%
|
2.79
|
| Change In Receivables |
|
-0.17
-302.79%
|
0.08
+349.80%
|
-0.03
-101.91%
|
1.73
|
| Changes In Account Receivables |
|
-0.09
-200.90%
|
0.09
+350.90%
|
-0.03
-123.93%
|
0.14
|
| Change In Inventory |
|
0.05
+135.98%
|
-0.13
|
0.00
|
0.00
|
| Change In Prepaid Assets |
|
-0.02
-132.09%
|
0.07
+12.43%
|
0.06
+181.42%
|
0.02
|
| Change In Payables And Accrued Expense |
|
0.14
+189.93%
|
-0.16
-125.67%
|
0.61
-43.51%
|
1.08
|
| Change In Payable |
|
0.14
+189.93%
|
-0.16
-125.67%
|
0.61
-43.51%
|
1.08
|
| Change In Account Payable |
|
-0.01
-180.97%
|
0.02
+1160.20%
|
0.00
|
0.00
|
| Change In Other Working Capital |
|
-0.02
-105.45%
|
0.45
|
—
|
—
|
| Change In Other Current Liabilities |
|
-0.20
-61.15%
|
-0.13
-18.02%
|
-0.11
-149.20%
|
-0.04
|
| Investing Cash Flow |
|
-0.10
+29.31%
|
-0.15
|
0.00
+100.00%
|
-0.27
|
| Cash Flow From Continuing Investing Activities |
|
-0.10
+27.78%
|
-0.14
|
0.00
+100.00%
|
-0.25
|
| Cash From Discontinued Investing Activities |
|
0.00
+100.00%
|
-0.00
|
0.00
+100.00%
|
-0.02
|
| Net PPE Purchase And Sale |
|
-0.08
+20.15%
|
-0.10
|
0.00
|
0.00
|
| Purchase Of PPE |
|
-0.08
+20.15%
|
-0.10
|
0.00
|
0.00
|
| Capital Expenditure |
|
-0.10
+9.98%
|
-0.12
|
—
|
-0.02
|
| Net Business Purchase And Sale |
|
—
|
—
|
—
|
-0.00
|
| Purchase Of Business |
|
—
|
—
|
—
|
-0.00
|
| Gain Loss On Sale Of Business |
|
—
|
—
|
—
|
-0.03
|
| Net Intangibles Purchase And Sale |
|
-0.03
-41.09%
|
-0.02
|
0.00
|
0.00
|
| Purchase Of Intangibles |
|
-0.03
-41.09%
|
-0.02
|
0.00
|
0.00
|
| Net Other Investing Changes |
|
—
|
-0.03
|
—
|
-0.25
|
| Financing Cash Flow |
|
2.55
+9.72%
|
2.32
-1.20%
|
2.35
-5.48%
|
2.49
|
| Cash Flow From Continuing Financing Activities |
|
2.55
+23.30%
|
2.07
-7.29%
|
2.23
-20.06%
|
2.79
|
| Net Issuance Payments Of Debt |
|
2.22
+2.62%
|
2.16
+49.87%
|
1.44
+3.02%
|
1.40
|
| Issuance Of Debt |
|
2.82
+3.55%
|
2.72
+88.06%
|
1.45
+2.96%
|
1.40
|
| Repayment Of Debt |
|
-0.60
-7.14%
|
-0.56
-9342.98%
|
-0.01
+8.57%
|
-0.01
|
| Long Term Debt Payments |
|
-0.01
-39.19%
|
-0.00
+25.15%
|
-0.01
+8.57%
|
-0.01
|
| Net Long Term Debt Issuance |
|
-0.01
-39.19%
|
-0.00
+25.15%
|
-0.01
+8.57%
|
-0.01
|
| Short Term Debt Issuance |
|
2.82
+3.55%
|
2.72
+88.06%
|
1.45
+2.96%
|
1.40
|
| Short Term Debt Payments |
|
-0.60
-6.88%
|
-0.56
|
0.00
|
0.00
|
| Net Short Term Debt Issuance |
|
2.22
+2.69%
|
2.16
+49.56%
|
1.45
+2.96%
|
1.40
|
| Net Common Stock Issuance |
|
0.00
-100.00%
|
0.05
-93.67%
|
0.79
-28.18%
|
1.10
|
| Proceeds From Stock Option Exercised |
|
0.10
|
0.00
|
0.00
|
—
|
| Net Other Financing Charges |
|
0.23
+266.34%
|
-0.14
|
—
|
0.29
|
| Changes In Cash |
|
0.02
-86.56%
|
0.14
+125.06%
|
-0.57
-181.48%
|
0.69
|
| Effect Of Exchange Rate Changes |
|
0.09
+187.05%
|
-0.10
-372.13%
|
-0.02
+78.34%
|
-0.10
|
| Beginning Cash Position |
|
0.24
+20.27%
|
0.20
-74.82%
|
0.78
+312.90%
|
0.19
|
| End Cash Position |
|
0.35
+45.26%
|
0.24
+20.27%
|
0.20
-74.82%
|
0.78
|
| Free Cash Flow |
|
-2.53
-17.68%
|
-2.15
+26.29%
|
-2.92
-91.11%
|
-1.53
|
| Interest Paid Supplemental Data |
|
0.01
-89.17%
|
0.06
+216.11%
|
0.02
-10.56%
|
0.02
|
| Income Tax Paid Supplemental Data |
|
0.03
+176.56%
|
0.01
-72.90%
|
0.04
-72.56%
|
0.16
|
| Change In Income Tax Payable |
|
-0.19
-403.45%
|
0.06
-28.37%
|
0.09
+333.71%
|
-0.04
|
| Change In Tax Payable |
|
-0.19
-403.45%
|
0.06
-28.37%
|
0.09
+333.71%
|
-0.04
|
| Common Stock Issuance |
|
0.00
-100.00%
|
0.05
-93.67%
|
0.79
-28.18%
|
1.10
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
0.05
-93.67%
|
0.79
-28.18%
|
1.10
|
| Sale Of Business |
|
—
|
—
|
—
|
—
|
| Cash From Discontinued Financing Activities |
|
0.00
-100.00%
|
0.26
+110.11%
|
0.12
+140.45%
|
-0.30
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-Q2023-07-31 View
- 10-K2023-06-28 View
- 42023-06-20 View
- 8-K2023-06-15 View
- 8-K2023-06-09 View
- 42023-05-26 View
- 8-K2023-05-26 View
- 8-K2023-05-24 View
- 8-K2023-05-19 View
- 8-K2023-05-19 View
- 8-K2023-05-11 View
- 8-K2023-04-10 View
- 8-K2023-03-15 View
- 8-K2023-03-07 View
- 8-K2023-03-01 View
- 8-K2023-02-17 View
- 8-K2023-01-31 View
- 42022-11-25 View
- 42022-11-25 View
- 42022-11-25 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|